Publication dates

All regions

Drug Therapy Industry, October 2014 Market Research & Statistics

You might be interested in: drug, medication, hospital, more »

1-10 of about 1 800 reports for Drug Therapy

Pathology Description in the US

  • Facts Spring 2014
  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

Pathology Description in the US

  • Diabetes and Cardiovascular Events in Hypertensive Patients
  • September 2014
    6 pages
  • Diabete  

    Blood  

    Sugar  

  • United States  

View report >

The future of the Pension Industry

  • Ageing Boomers: how Wealth and Health will Shape Retirement
  • September 2014
    6 pages
  • Pension  

    Healthcare  

  • United States  

    World  

    Europe  

View report >

Drug Industry - Forecast

  • The 2013 Drug Trend Report
  • January 2013
    91 pages
  • Drug  

View report >

Pathology Description in the UK

  • Autism Spectrum Disorder: Public Awareness and Attitudes
  • January 2013
    4 pages
  • Autism  

  • United Kingdom  

View report >

Drug Markets in the US

  • For Reprints, Links & Permissions
  • September 2014
    17 pages
  • Drug  

  • United States  

View report >

Drug Markets in the US

  • For Reprints, Links & Permissions
  • September 2014
    17 pages
  • Drug  

  • United States  

View report >

Pharmacy Markets in Canada and the UK - Forecast

  • Bcpha Submission: Select Standing Committee on Finance and Gover...
  • January 2013
    22 pages
  • Pharmacy  

  • Canada  

    United Kingdom  

    United States  

View report >

Pathology Description in the US

  • Tuesday, March 5, 2013
  • March 2013
    7 pages
  • Pathology  

    Cancer  

  • United States  

View report >

Pathology Description in Europe

  • European Heart Journal Advance Access Published August 31, 2014
  • August 2014
    12 pages
  • Pathology  

    Atrial Fibrilla...  

    Neurological Di...  

  • Europe  

View report >
9 reports for Drug Therapy

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 6 500)

Chronic Lymphocytic Leukaemia: KOL Insight

Chronic Lymphocytic Leukaemia: KOL Insight

  • $ 5 369
  • Industry report
  • May 2014
  • by Firstword Pharma

Chronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until recently it has been underserved in terms of effective therapeutic options. However, a revolution in personalised and ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.